The University Of Pittsburgh School Of Medicine was named an American Parkinson Disease Association Center for Advanced Research this year. The APDA is the nation’s largest grassroots Parkinson’s organization and has been providing patient and caregiver support, free educational materials and scientific research support for 45 years.
Pitt joins a network of eight APDA centers at major universities and healthcare centers across the U.S. Centers are located at Boston University School of Medicine; Emory University School of Medicine, Atlanta; UCLA School of Medicine, Los Angeles; the University of Alabama at Birmingham; University of Virginia Medical Center, Charlottesville; UMDNJ-Robert Wood Johnson Medical School, New Brunswick; and Washington University Medical Center, St. Louis. Each center receives a minimum of $100,000 a year for five years, based upon satisfactory annual progress and financial reports.
J. Timothy Greenamyre, MD, PhD, Professor and Chief of Movement Disorders Division, Department of Neurology and director of the Pittsburgh Institute for Neurodegenerative Diseases, will direct the Pitt center.
Two Pitt scientists from the Department of Neurology were awarded research grants for their work in seeking the cause of and cure for the neurological degenerative disease. Sarah Berman, MD, PhD, Assistant Professor of Neurology, and Rehana Leak, PhD, Research Associate, were among 34 recipients of one-year, $50,000 research grants from the ADPA. Dr. Berman’s study is titled “Mitochondrial dynamics in vulnerability and protection of aging neurons in Parkinson’s disease” while Dr. Leak will focus her research on “Preconditioning-induced neuroprotection in models of Parkinson’s disease.”